(Q47658882)

English

Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

Udo Bonnet

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

publication date

28 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

Journal of Psychoactive Drugs

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

47

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

276-285

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

On the safety and benefits of repeated intravenous injections of ketamine for depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine: an update on its abuse

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Adaptive plasticity of NMDA receptors and dendritic spines: implications for enhanced vulnerability of the adolescent brain to alcohol addiction

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Acute antidepressant effects of intramuscular versus intravenous ketamine.

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Intramuscular ketamine in acute depression: A report on two cases

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Signaling pathways underlying the rapid antidepressant actions of ketamine

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

The mechanisms of tolerance in antidepressant action

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine administration in depressive disorders: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Dose- and exposure-response to ketamine in depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine dependence in an anesthesiologist: an occupational hazard?

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A review of the nonmedical use of ketamine: use, users and consequences

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

The nonmedical use of ketamine, part two: A review of problem use and dependence

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine as a new treatment for depression: a review of its efficacy and adverse effects

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Synaptic mechanisms underlying rapid antidepressant action of ketamine

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Pilot dose-response trial of i.v. ketamine in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A randomized controlled trial of intranasal ketamine in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Long-lasting alterations in membrane properties, k(+) currents, and glutamatergic synaptic currents of nucleus accumbens medium spiny neurons in a rat model of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine use: a review

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Role of nucleus accumbens glutamatergic plasticity in drug addiction

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Serial infusions of low-dose ketamine for major depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Clinically relevant concentrations of ketamine mainly affect long-term potentiation rather than basal excitatory synaptic transmission and do not change paired-pulse facilitation in mouse hippocampal slices

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Limbic over-activity in depression during preserved performance on the n-back task.

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006).

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine – More mechanisms of action than just NMDA blockade

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

The prevalence and impact of alcohol problems in major depression: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

The neurobiology of alcohol consumption and alcoholism: an integrative history

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Rapid response with ketamine on suicidal cognition in resistant depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A systems model of altered consciousness: integrating natural and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine : from medicine to misuse

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Acute and chronic effects of ethanol on learning-related synaptic plasticity.

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2015.1072653

21 January 2018

Identifiers

10.1080/02791072.2015.1072653

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/26317449

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47658882&oldid=2164365826"